Treatment of Aeromonas Infections
Introduction to Treatment Recommendations
- The Infectious Diseases Society of America recommends doxycycline plus either ciprofloxacin or ceftriaxone as the first-line treatment for Aeromonas infections 1, 2, 3, 4
Treatment Recommendations by Infection Type
- For necrotizing infections caused by Aeromonas hydrophila, the recommended treatment is doxycycline 100 mg every 12 hours IV plus either ciprofloxacin 500 mg every 12 hours IV or ceftriaxone 1-2 g every 24 hours IV 1
- For severe infections, combination therapy is preferred over monotherapy to prevent the development of resistance 5
- The treatment duration should be at least 7 days for uncomplicated infections and 10-14 days for severe infections 5
- For Aeromonas-associated diarrhea or colitis, the recommended treatment is trimethoprim-sulfamethoxazole 160/800 mg twice daily for 3 days (if susceptible) or fluoroquinolones (e.g., ciprofloxacin 500 mg twice daily for 3 days) 6
- For bloodstream infections, the recommended treatment is combination therapy with doxycycline plus ciprofloxacin or ceftriaxone 1
- The treatment duration for bloodstream infections should be 10-14 days 5
- For immunocompromised patients with bloodstream infections, consider extending the treatment duration 6
Antimicrobial Susceptibility Considerations
- For empiric therapy, combination treatment is preferred to prevent the development of resistance 5
Special Populations
- For immunocompromised patients, use the same antimicrobial agents as for immunocompetent patients but consider longer treatment duration 6
- For pediatric patients, doxycycline is generally not recommended but may be used in life-threatening Aeromonas infections 1
- Alternative agents for children include trimethoprim-sulfamethoxazole (if susceptible) or third-generation cephalosporins 6
Algorithm for Treatment Selection
- For severe infections, the first choice of treatment is doxycycline 100 mg every 12 hours IV plus ciprofloxacin 500 mg every 12 hours IV 1, 2, 3
- Adjust therapy based on culture and susceptibility results when available 6
- Continue treatment for 7-14 days depending on infection site and clinical response 5